Variant report
Variant | nsv598417 |
---|---|
Chromosome Location | chr5:68319593-68320494 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:68312049..68314191-chr5:68317998..68320759,3 | K562 | blood: | |
2 | chr5:68312049..68313667-chr5:68319112..68320759,2 | K562 | blood: | |
3 | chr5:68319293..68321703-chr5:68323264..68324934,2 | K562 | blood: | |
4 | chr14:47749473..47749973-chr5:68319722..68320581,2 | MCF-7 | breast: | |
5 | chr5:68319705..68320603-chr5:68630318..68631248,3 | K562 | blood: | |
6 | chr5:68320167..68322088-chr5:68342197..68344022,2 | K562 | blood: | |
7 | chr5:68319643..68320584-chr5:68379379..68380063,3 | K562 | blood: | |
8 | chr5:68319742..68320506-chr5:68379422..68380332,4 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CCDC125-13 | chr5:68320037-68320857 | NONHSAT101881 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142747957 | chr5:68319618-68319619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376644364 | chr5:68319672-68319673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12697069 | chr5:68319687-68319688 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs543502511 | chr5:68319688-68319689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9885496 | chr5:68319711-68319712 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs565106548 | chr5:68319734-68319735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529260840 | chr5:68319735-68319736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547436167 | chr5:68319751-68319752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116578808 | chr5:68319763-68319764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370759054 | chr5:68319786-68319787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552072017 | chr5:68319799-68319800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570527650 | chr5:68319888-68319889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114296859 | chr5:68319901-68319902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116459730 | chr5:68319976-68319977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568189880 | chr5:68320057-68320058 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs192159884 | chr5:68320126-68320127 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs374454021 | chr5:68320165-68320166 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs147417759 | chr5:68320236-68320237 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs572086493 | chr5:68320238-68320239 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs564209281 | chr5:68320267-68320268 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs540109892 | chr5:68320352-68320353 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs184723840 | chr5:68320361-68320362 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs189654509 | chr5:68320428-68320429 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs544033530 | chr5:68320430-68320431 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs180782660 | chr5:68320434-68320435 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Lung cancer | 17086460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68318400-68320200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr5:68320200-68320400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr5:68320200-68320800 | Enhancers | K562 | blood |
4 | chr5:68320400-68327000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |